Hepatitis C Virus Treatment: Simplifying the Simple and Optimizing the Difficult.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33245350.
- Also identified by DOI 10.1093/infdis/jiaa534 and PMC identifier 8171802.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The availability of safe, efficacious, oral direct-acting antivirals (DAAs) have ushered in a new era of hepatitis C treatment with potential to eliminate hepatitis C as a public health threat. To achieve population-level effectiveness of these oral DAAs, hepatitis C treatment by a wide range of providers in different settings will be essential to increase the number of persons treated. We provide a clinical review of hepatitis C treatment with a focus on practical tools for management of hepatitis C in majority of currently infected individuals who can be easily cured and optimization of treatment for those in whom treatment may not be as simple.
Medical subject headings
- Antiviral Agents
- Hepatitis C